Doctor profile · Federal record
Dr. David Chamberland, MD
Rheumatology Physician (CMS: Rheumatology) · Medford, OR
- NPI 1447293311
- Accepts Medicare
- MIPS 73.5 / 100 · 2023
- 25 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1365 Poplar Dr
Medford, OR 975045207
(541) 773-2233
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 20, 2014
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Oregon #MD26693
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447293311. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
216,173
Distinct HCPCS
10
Medicare allowed
$3,592,676
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 99,020 | 23 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 30,350 | 34 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 29,525 | 52 | $42 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 26,800 | 11 | $5 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 8,590 | 43 | $33 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 5,210 | 42 | $41 | |
J9312 |
Injection, rituximab, 10 mg | 3,970 | 16 | $80 | |
J0897 |
Injection, denosumab, 1 mg | 2,580 | 26 | $23 | |
J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1,296 | 15 | $10 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,151 | 495 | $124 |
In context: peer comparison
Among 1 peers in Medford Rheumatology Physician, average services per provider: 4,157. This provider delivers 52× the peer median.Open Payments
Industry payments received
All-time total
$65
Transactions
4
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 1 | $21.59 | |
| Celgene Corporation | 1 | $15.60 | |
| Novartis Pharmaceuticals Corporation | 1 | $14.19 | |
| Abbvie INC. | 1 | $14.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,133
Patients
658
Total drug cost
$496,520
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 613 | 183 | $25,362 |
| Prednisone | Generic | 413 | 162 | $5,494 |
| Hydroxychloroquine Sulfate | Generic | 317 | 91 | $20,086 |
| Leflunomide | Generic | 127 | 40 | $12,047 |
| Sulfasalazine | Generic | 115 | 42 | $4,739 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 91 | 22 | $3,270 |
| Leucovorin Calcium | Generic | 66 | 21 | $818 |
| Tramadol Hcl | Generic | 66 | 17 | $645 |
| Folic Acid | Generic | 62 | 22 | $351 |
| Humira(Cf) Pen (Adalimumab) | Brand | 58 | 0 | $416,644 |
Hospital affiliations
Frequently asked questions
What is Dr. David Chamberland's medical specialty?
Dr. David Chamberland practices Rheumatology Physician in Medford, OR.
Where does Dr. David Chamberland practice?
Dr. David Chamberland practices at 1365 Poplar Dr, Medford, OR 975045207. Office phone: 5417732233.
What is Dr. David Chamberland's NPI?
Dr. David Chamberland's National Provider Identifier (NPI) is 1447293311, issued by NPPES.
Does Dr. David Chamberland accept Medicare assignment?
Yes. Dr. David Chamberland accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Chamberland commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.